Phase 3 Trial Paused for CP101 in Recurrent C. difficle Infection
March 11th 2022Finch was still able to continue dosing patients in its past-ongoing PRISM-EXT phase 2 open-label trial of CP101 in recurrent CDI, because the CP101 lots used for PRISM-EXT were manufactured from material donated prior to December 1, 2019.
Read More
Experts Examine Ways to Reduce Global Burden of Depression
March 10th 2022The commission “Time for United Action on Depression,” authored by 25 experts from 11 countries, seeks to unify global efforts among governments, health care providers, researchers, people living with depression, and their families to improve care and prevention, fill knowledge gaps, and increase awareness.
Read More